(Q38069234)

28 August 2017

1 reference

title

Regenerative medicine interventions for orthopedic disorders: ethical issues in the translation into patients (English)

1 reference

28 August 2017

0 references

1 reference

regenerative medicine

1 reference

4

Annelien L Bredenoord

1 reference

28 August 2017

1

Sophie L Niemansburg

1 reference

28 August 2017

author name string

Johannes Jm van Delden

series ordinal

2

1 reference

28 August 2017

Wouter Ja Dhert

series ordinal

3

1 reference

28 August 2017

publication date

1 January 2013

1 reference

28 August 2017

published in

Regenerative Medicine

1 reference

28 August 2017

volume

8

1 reference

28 August 2017

issue

1

1 reference

28 August 2017

page(s)

65-73

1 reference

Engineering tissues, organs and cells

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2217%2FRME.12.112

A proposed definition of regenerative medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FRME.12.112

Cell delivery therapeutics for musculoskeletal regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FRME.12.112

An exploratory survey on the views of European tissue engineers concerning the ethical issues of tissue engineering research.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FRME.12.112

The risk-benefit task of research ethics committees: an evaluation of current approaches and the need to incorporate decision studies methods

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FRME.12.112

The need to explicate the ethical evaluation tools to avoid ethical inflation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FRME.12.112

The ethical analysis of risk

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FRME.12.112

Ethical reflections on clinical trials with human tissue engineered products

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FRME.12.112

Challenges with advanced therapy medicinal products and how to meet them.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FRME.12.112

2009 ISSLS Prize Winner: Does discography cause accelerated progression of degeneration changes in the lumbar disc: a ten-year matched cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FRME.12.112

Informing participants in clinical trials with ex vivo human tissue-engineered products: what to tell and how to tell it?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FRME.12.112

Defining and describing benefit appropriately in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FRME.12.112

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FRME.12.112

A review of the 2001 Volvo Award winner in clinical studies: lumbar fusion versus nonsurgical treatment for chronic low back pain: a multicenter randomized controlled trial from the Swedish lumbar spine study group

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FRME.12.112

Potential of magnetic resonance imaging findings to refine case definition for mechanical low back pain in epidemiological studies: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FRME.12.112

Osteoarthritis: MR imaging findings in different stages of disease and correlation with clinical findings

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FRME.12.112

The Longitudinal Assessment of Imaging and Disability of the Back (LAIDBack) Study: baseline data.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FRME.12.112

What is the best standard for the standard of care in clinical research?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FRME.12.112

Ethical framework for the use of sham procedures in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FRME.12.112

Sham surgery: an ethical analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FRME.12.112

Developing a placebo-controlled trial in surgery: issues of design, acceptability and feasibility

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FRME.12.112

The ethical problems with sham surgery in clinical research

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FRME.12.112

Progress and Prospects: genetic treatments for disorders of bones and joints

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FRME.12.112

First-in-human trial participants: not a vulnerable population, but vulnerable nonetheless

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FRME.12.112

Target populations for first-in-human embryonic stem cell research in spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FRME.12.112

Scaffolding in tissue engineering: general approaches and tissue-specific considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FRME.12.112

Tissue engineering and the intervertebral disc: the challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FRME.12.112

Adjacent level disk disease--is it really a fusion disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FRME.12.112

Biological repair of the degenerated intervertebral disc by the injection of growth factors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FRME.12.112

Bone morphogenetic proteins in orthopaedic surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FRME.12.112

From osteoarthritis treatments to future regenerative therapies for cartilage.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FRME.12.112

Orthopedic gene therapy in 2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FRME.12.112

Biological treatment strategies for disc degeneration: potentials and shortcomings

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FRME.12.112

Cell-based therapy for disc repair

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FRME.12.112

Tissue engineering of functional articular cartilage: the current status

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FRME.12.112

In vivo tissue engineering of musculoskeletal tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FRME.12.112

Diagnostic Evaluation of LBP

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FRME.12.112

Standard of Care in Clinical Research with Human Tissue Engineered Products (HTEPs)

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FRME.12.112

21 January 2018

Identifiers

DOI

10.2217/RME.12.112

1 reference

28 August 2017

1 reference